Home
Storia in 6 fonti
Baxfendy approved for uncontrolled hypertension
AstraZeneca announced the FDA approved baxdrostat for uncontrolled hypertension as add-on therapy on top of standard care.Baxdrostat (Baxfendy) is the first aldosterone synthase inhibitor approved to treat uncontrolled high blood pressure in people with primary aldosteronism, a hormonal disorder that promotes sodium and water retention, according to a company press release.
- ·
healio.com
Baxfendy approved for uncontrolled hypertension
AstraZeneca announced the FDA approved baxdrostat for uncontrolled hypertension as add-on therapy on top of standard care.Baxdrostat (Baxfendy) is the first aldosterone synthase…
- ·
astrazeneca.com
Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with…
